Old Web
English
Sign In
Acemap
>
authorDetail
>
James C. Yang
James C. Yang
National Institutes of Health
Pathology
Medicine
Melanoma
Renal cell carcinoma
Prospective cohort study
3
Papers
327
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma
2002
Cancer
Andrew L Feldman
H. Richard Alexander
James C. Yang
W. Marston Linehan
A R N Robin Eyler
S B S Marshall Miller
Seth M. Steinberg
Steven K. Libutti
Show All
Source
Cite
Save
Citations (72)
The Use of Polyethylene Glycol-Modified Interleukin-2 (PEG-IL-2) in the Treatment of Patients with Metastatic Renal Cell Carcinoma and Melanoma A Phase I Study and a Randomized Prospective Study Comparing IL-2 Alone versus IL-2 Combined with PEG-IL-2
1995
Cancer
James C. Yang
Suzanne L. Topalian
Douglas J. Schwartzentruber
David R. Parkinson
Francesco M. Marincola
Jeffrey S. Weber
A R N Claudia Seipp
Donald E. White
Steven A. Rosenberg
Show All
Source
Cite
Save
Citations (69)
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy: Augmentation with cyclophosphamide and correlation with response
1994
Cancer
Barbara A. Pockaj
Richard M. Sherry
John P. Wei
John R. Yannelli
S B S Charles Carter
Susan F. Leitman
Jorge A. Carasquillo
Seth M. Steinberg
Steven A. Rosenberg
James C. Yang
Show All
Source
Cite
Save
Citations (186)
1